Leerink Partners cuts Rocket Pharmaceuticals target price to $4 from $7
RCKT•Leerink Partners cut its target price for Rocket Pharmaceuticals to $4 from $7.
Related News
QuickLogic files Form 3 for SVP Finance and CFO James Sullivan
QUIK•
Australian uranium stocks gain after Google's power deal with Constellation Energy
URA•
JGB yields track global bond rally; dovish BOJ member reportedly signals support for hikes
TLT•
First Community director Fred Joseph Deutsch disposes of shares worth $15
FCCO•
Trump says nobody knows who is running Iran
USO•